Antibody Therapies Against TDP-43 Protein Clumps Focus of Research

Antibody Therapies Against TDP-43 Protein Clumps Focus of Research

312591

Antibody Therapies Against TDP-43 Protein Clumps Focus of Research

BioArctic AB announced that it is advancing work into selective antibodies against TAR DNA-binding protein 43 (TDP-43) that when misfolded can form the toxic clumps, or aggregates, believed to be involved in the development of amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. One potential therapy approach is called the ND3014 project and early research into it is underway, the company, based in Sweden, reported. “BioArctic’s scientists work in a systematic way to identify new methods to address…

You must be logged in to read/download the full post.